Perspectives for the Therapy against Arenavirus Infections

Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats

Volumn , Issue , 2005, Pages 115-138

  Damonte, Elsa B ^a   García, Cybele C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antiviral therapy; Arenavirus; Assembly; Budding; Hemorrhagic fever; Junin Virus; Lassa Virus; Replicative cycle; Virus entry; Virus maturation

Indexed keywords

EID: 46149084987     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471716715.ch5     Document Type: Chapter

References (147)

1. Clegg, J. C. S.; Bowen, M. D.; Buchmeier, M. J.; Gonzalez, J. P.; Lukashevich, I. S.; Peters, C. J.; Rico-Hesse, R.; Romanowski, V. Family Arenaviridae. In Virus Taxonomy. Seventh Report of the International Committee for the Taxonomy of Viruses, Regenmortel, M. H. V.; van, Fauquet, C. M.; Bishop, D. H. L.; Carstens, E. B.; Estes, M. K.; Lemon, S. M.; Maniloff, J.; Mayo, M. A.; McGeoch, D. J.; Pringle, C. R.; Wickner, R. B. (eds.). Academic Press, Orlando, 2000, pp. 633-640.
2. Wulff, H.; Lange, J. V.; Webb, P. A. Interrelationships among arenaviruses measured by indirect immunofluorescence. Intervirology 1978, 9, 344-350.
3. Howard, C. R. Antigenic diversity among the arenaviruses. In The Arenaviridae, Salvato, M. S. (ed.). Plenum Press, New York, 1993, pp. 37-49.
4. Armstrong, C. R.; Lillie, R. D. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St. Louis encephalitis epidemic. Public Health Rep. (Washington) 1934, 50, 831-842.
5. Frame, J. D.; Baldwin, J. M. Jr.; Gocke, D. J.; Troup, J. M. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg. 1970, 19, 670-676.
6. Wulff, H.; McIntosh, B. M.; Hammer, D. B.; Johnson, K. M. Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in South-East Africa. Bull. WHO 1977, 55, 441-444.
7. Gonzalez, J. P.; McCormick, J. B.; Saluzzo, J. F.; Herve, J. P.; Georges, A. J.; Johnson, K. M. An arenavirus isolated from wild-caught rodents (Praomys species) in the Central African Republic. Intervirology 1983, 19, 105-112.
8. Swanepoel, R.; Leman, P. A.; Shepherd, A. J.; Shepherd, S. P.; Kiley, M. P.; McCormick, J. B. Identification of Ippy virus as a Lassa-fever related virus. Lancet 1985, 1, 639.
9. Parodi, A. S.; Greenway, D. Y.; Rugiero, H. R.; Rivero, E.; Frigerio, M. J.; Mettler, N. E.; Garzon, F.; Boxaca, M.; Guerrero, L. B. de; Nota, N. R. Sobre la etiología del brote epidemico en Junín. Día Med. 1958, 30, 2300-2302.
10. Downs, W. G.; Anderson, C. R.; Spence, L.; Aitken, T. H. G.; Greenhall, A. H. Tacaribe virus, a new agent isolated from Artibeus bats and mosquitoes in Trinidad, West Indies. Am. J. Trop. Med. Hyg. 1963, 12, 640-642.
11. Johnson, K. M.; Kuns, M. L.; Mackenzie, R. B.; Webb, P. A.; Yunker, C. E. Isolation of Machupo virus from wild rodent Calomys callosus. Am. J. Trop. Med. Hyg. 1966, 15, 103-106.
12. Pinheiro, F. P.; Shope, R. E.; de Andrade, A. H. P.; Bensabath, G.; Cacios, G. V.; Casals, J. Amapari, a new virus of the Tacaribe group from rodents and mites of Amapa territory, Brazil. Proc. Soc. Exp. Biol. Med. 1966, 122, 531-535.
13. Webb, P. A.; Johnson, K. M.; Hibbs, J. B.; Kuns, M. L. Parana, a new Tacaribe complex virus from Paraguay. Arch. Ges. Virusforsch. 1970, 32, 379-388.
14. Trapido, H.; San Martín, C. Pichinde virus. A new virus of the Tacaribe group from Colombia. Am. J. Trop. Med. Hyg. 1971, 20, 631-641.
15. Webb, P. A.; Johnson, K. M.; Peters, C. J.; Justines, G. Behaviour of Machupo and Latino viruses in Calomys callosus from two geographic areas of Bolivia. In Lymphocytic Choriomeningitis Virus and Other Arenaviruses, Lehmann-Grube, F. (ed.). Springer Verlag, Berlin, 1973, pp. 313-321.
16. Pinheiro, F. P.; Woodall, J. P.; Da Rosa, A. P. A. T.; Da Rosa, J. F. T. Studies of Arenaviruses in Brazil. Medicina (Buenos Aires) 1977, 37(Suppl. 3), 175-181.
17. Tesh, R. B.; Jarhling, P. B.; Salas, R. A.; Shope, R. E. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am. J. Trop. Med. Hyg. 1994, 50, 452-459.
18. Coimbra, T. L. M.; Nassar, E. S.; Burattini, M. N.; de Souza, L. T. M.; Ferreira, I. B.; Rocco, I. M.; Travassos da Rosa, A. P.; Vasconcelos, P. F. C.; Pinheiro, F. P.; Le Duc, J. W.; Rico-Hesse, R.; Gonzalez, J.-P.; Jahrling, P. B.; Tesh, R. B. New arenavirus isolated in Brazil. Lancet 1994, 343, 391-392.
19. Bowen, M. D.; Peters, C. J.; Mills, J. M.; Nichol, S. T. Oliveros virus: a novel Arenavirus from Argentina. Virology 1966, 217, 362-366.
20. Fulhorst, C. F.; Bowen, M. D.; Salas, R. A.; deManzione, N. M. C.; Duno, G.; Utrera, A.; Ksiazek, T. G.; Peters, C. J.; Nichol, S. T.; de Miller, E.; Tovar, D.; Ramos, B.; Vasquez, C.; Tesh, R. B. Isolation and characterization of Pirital virus, a newly discovered South American arenavirus. Am. J. Trop. Med. Hyg. 1997, 56, 558-553.
21. Lozano, M. E.; Posik, D. M.; Albarino, C. G.; Schujman, G.; Ghiringhelli, P. D.; Calderón, G.; Sabattini, M. S.; Romanowski, V. Characterization of arenaviruses using a family-specific primer set of RT-PCR amplification and RFLP analysis: its potential use for detection of uncharacterized arenaviruses. Virus Res. 1997, 49, 79-89.
22. Moncayo, A. C.; Hice, C. L.; Watts, D. M.; Travassos de Rosa, A. P. A.; Guzman, H.; Russell, K. L.; Calampa, C.; Gozalo, A.; Popov, V. L.; Weaver, S. C.; Tesh, R. B. Allpahuayo virus: a newly recognized arenavirus (Arenaviridae) from arboreal rice rats (Oecomys bicolor and Oecomysparicola) in northeastern Peru. Virology 2001, 284, 277-286.
23. Charrel, R. N.; Feldmann, H.; Fulhorst, C. F.; Khelifa, R.; de Chesse, R.; de Lamballerie, X. Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination. Biochem. Biophys. Res. Commun. 2002, 296, 1118-1124.
24. Jennings, W. L.; Lewis, A. L.; Sather, G. E.; Pierce, L. V.; Bond, J. O. Tamiami virus in the Tampa Bay area. Am. J. Trop. Med. Hyg. 1970, 19, 527-536.
25. Fulhorst, C. F.; Bowen, M. D.; Ksiazek, T. G.; Rollin, P. E.; Nichol, S. T.; Kosoy, M. Y.; Peters, C. J. Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology 1996, 224, 114-120.
26. Fulhorst, C. F.; Bennett, S. G.; Milazzo, M. L.; Murray, H. L.; Webb, J. P.; Cajimat, M. N. B.; Bradley, R. B. Bear Canyon virus: an arenavirus naturally associated with the California mouse (Peromyscus californicus). Emerging Infect. Dis. 2002, 8, 717-721.
27. Bowen, M. D.; Peters, C. J.; Nichol, S. T. The phylogeny of New World (Tacaribe complex) arenaviruses. Virology 1996, 219, 285-290.
28. Archer, A. A.; Rico-Hesse, R. High genetic divergence and recombination in arenaviruses from the Americas. Virology 2002, 304, 274-281.
29. Clegg, J. C. S. Molecular phylogeny of the arenaviruses. Curr. Top. Microbiol. Immunol. 2002, 262, 1-24.
30. Charrel, R. N.; Lemasson, J. J.; Garbutt, M.; Khelifa, R.; De Micco, P.; Feldmann, H.; de Lamballerie, X. New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. Virology 2003, 317, 191-196.
31. Salazar-Bravo, J.; Ruedas, L. A.; Yates, T. L. Mammalian reservoirs of arenaviruses. Curr. Top. Microbiol. Immunol. 2002, 262, 26-63.
32. Rotz, L. D.; Khan, A. S.; Lillibridge, S. R.; Ostroff, S. M.; Hughes, J. M. Public health assessment of potential biological terrorism agents. Emerging Infect. Dis. 2002, 8, 225-230.
33. Compans, R. W. Arenavirus ultrastructure and morphogenesis. In The Arenaviridae, Salvato, M. S. (ed.). Plenum Press, New York, 1993, pp. 3-16.
34. Rowe, W. P.; Murphy, F. A.; Bergold, G. H.; Casals, J.; Hotchin, J.; Johnson, K. M.; Lehmann-Grube, F.; Mims, C. A.; Traub, E.; Webb, P. A. Arenaviruses: proposed name for a newly defined virus group. J. Virol. 1970, 5, 651-652.
35. Leung, W. C.; Rawls, W. E. Virion-associated ribosomes are not required for the replication of Pichinde virus. Virology 1977, 81, 174-176.
36. Romanowski, V.; Bishop, D. H. L. The formation of arenaviruses that are genetically diploid. Virology 1983, 126, 87-95.
37. Southern, P. J.; Singh, M. K.; Riviere, Y.; Jacoby, D. R.; Buchmeier, M. J.; Oldstone, M. B. A. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology 1987, 157, 145-155.
38. Iapalucci, S.; Chernavsky, A.; Rossi, C.; Burgín, M. J.; Franze-Fernandez, M. T. Tacaribe virus gene expression in cytopathic and non-cytopathic infections. Virology 1994, 200, 613-622.
39. Meyer, B. J.; de la Torre, J. C.; Southern, P. J. Arenaviruses: genomic RNAs, transcription and replication. Curr. Top. Microbiol. Immunol. 2002, 262, 139-157.
40. Peters, C. J. Human infections with arenaviruses in the Americas. Curr. Top. Microbiol. Immunol. 2002, 262, 65-74.
41. Manzione, R. de; Salas, R. A.; Paredes, H.; Godoy, O.; Rojas, L.; Araoz, F.; Fulhorst, C. F.; Ksiazek, T. G.; Mills, J. N.; Ellis, B. A.; Paters, C. J.; Tesh, R. B. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin. Infect. Dis. 1998, 26, 308-313.
42. Barry, M.; Russi, M.; Armstrong, L.; Geller, D. L.; Tesh, R.; Dembry, L.; Gonzalez, J. P.; Khan, A.; Peters, C. J. Treatment of a laboratory-acquired Sabia virus infection. N. Engl. J. Med. 1995, 333, 294-296.
43. McCormick, J. B.; Fisher-Hoch, S. P. Lassa fever. Curr. Top. Microbiol. Immunol. 2002, 262, 73-109.
44. Monath, T. P.; Mertens, P. E.; Patton, R.; Moser, C. R.; Baum, J. J.; Pinneo, L; Gary, G. W.; Kissling, R. E. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am. J. Trop. Med. Hyg. 1973, 22, 773-779.
45. Maiztegui, J. I. Clinical and epidemiological patterns of Argentine hemorrhagic fever. Bull. WHO 1975, 52, 567-575.
46. Enría, D. A.; Briggiler, A. M.; Fernandez, N. J.; Levis, S. C.; Maiztegui, J. I. Importance of dose of neutralizing antibodies in treatment of Argentine hemorrhagic fever with immune plasma. Lancet 1984, 8397 (11), 255-256.
47. Maiztegui, J. I.; Fernandez, N.; Damilano, A. J. Efficacy of immune plasma in treatment of Argentine hemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 1979, 8154 (11), 1216-1217.
48. Enría, D. A.; Maiztegui, J. I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 1994, 23, 23-31.
49. McCormick, J. B.; King, I. J.; Webb, P. A.; Scribner, C. L.; Craven, R. B.; Johnson, K. M.; Elliot, L. H.; Belmont-Williams, R. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 1986, 314, 20-26.
50. Streeter, D. G.; Witkowski, J. T.; Khare, G. P.; Sidwell, R. W.; Bauer, R. J.; Robins, R. K.; Simon, L. N. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. U.S.A. 1973, 70, 1174-1178.
51. Gilbert, B. E.; Knight, V. (1986). Biochemistry and clinical application of ribavirin. Antimicrob. Agents Chemother. 1986, 30, 201-205.
52. Goswami, B. B.; Borek, E.; Sharma, O. K.; Fujitaki, J.; Smith, R. A. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem. Biophys. Res. Commun. 1979, 89, 830-836.
53. Crotty, S.; Maag, D.; Arnold, J. J.; Zhong, W.; Lau, J. Y. N.; Hong, Z.; Andino, R.; Cameron, C. E. The broad-spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen. Nat. Med. 2000, 6, 1375-1379.
54. Crotty, S.; Cameron, C. E.; Andino, R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 6895-6900.
55. Ruiz-Jarabo, C. M.; Ly, C.; Domingo, E.; de la Torre, J. C. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 2003, 308, 37-47.
56. Tam, R. C.; Lau, J. Y. N.; Hong, Z. Mechanisms of action of ribavirin in antiviral therapies. Antiviral Chem. Chemother. 2002, 12, 261-272.
57. Wyde, P. R. Respiratory syncytial virus (RSV) disease and prospects for its control. Antiviral Res. 1998, 39, 63-79.
58. Walker, M. P.; Appleby, T. C.; Zhong, W.; Lau, J. Y. N.; Hong, Z. Hepatitis C virus therapies: current treatments, targets and future perspectives. Antiviral Chem. Chemother. 2003, 14, 1-21.
59. Jahrling P. B.; Hesse, R. A.; Eddy, G. A.; Johnson, K. M.; Callis, R. T.; Stephen, E. L. (1980). Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 1980, 141, 580-589.
60. McKee, K. T.; Huggins, J. W.; Trahan, C. J.; Mahlandi, B. G. Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever. Antimicrob. Agents Chemother. 1988, 32, 1304-1309.
61. Kenyon, R. H.; Canonico, P. G.; Green, D. G.; Peters, C. J. Effect of ribavirin and tributylribavirin on Argentine hemorrhagic fever (Junin virus) in guinea pigs. Anti-microb. Agents Chemother. 1986, 29, 521-523.
62. Weissenbacher, M. C.; Avila, M. M.; Calello, M. A.; Merani, M. S.; McCormick, J. B.; Rodriguez, M. Effect of ribavirin and immune serum on Junin virus infected primates. Med. Microbiol. Immunol. 1986, 175, 183-186.
63. Enría, D. A.; Briggiler, A. M.; Levis, S.; Vallejos, D.; Maiztegui, J. I.; Canonico, P. G. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res. 1987, 7, 353-359.
64. Huggins, J. W.; Robins, R. K.; Canonico, P. G. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunya-viruses, and arenaviruses. Antimicrob. Agents Chemother. 1984, 26, 476-480.
65. Burns, N. J. III; Barnett, B. B.; Huffman, J. H.; Dawson, M. Y.; Sidwell, R. W.; De Clercq, E.; Kende, M. A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues. Antiviral Res. 1988, 10, 89-98.
66. Smee, D. F.; Gilbert, J.; Leonhardt, J. A.; Barnett, B. B.; Huggins, J. H.; Sidwell, R. W. Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res. 1993, 20, 57-70.
67. Andrei, G.; De Clercq, E. Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res. 1990, 14, 287-300.
68. Smee, D. F.; Morris, J. L. B.; Barnard, D. L.; Van Aerschot, A. Selective inhibition of arthropod-borne and arenaviruses by 3'-fluoro-3'-deoxyadenosine. Antiviral Res. 1992, 18, 151-162.
69. Guillerm, G.; Guillerm, D.; Vandenplas-Vitkowski, C.; Glapski, C.; De Clercq, E. Inactivation of S-adenosyl-L-homocysteine hydrolase with novel 5'-thioadenosine derivatives. Antiviral effects. Bioorg. Med. Chem. Lett. 2003, 13, 1649-1652.
70. Martins Alho, M. A.; Sguerra, V. L.; Talarico, L. B.; García, C. C.; Damonte, E. B.; D'Accorso, N. Unpublished results, 2004.
71. Uckun, F. M.; Petkevich, A. S.; Vassilev, A. O.; Tibbles, H. E.; Titov, L. Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by Lassa virus. BMC Infect. Dis. 2004, 4, 1-7.
72. Burns, J. W.; Buchmeier, M. J. Protein-protein interactions in lymphocytic choriomeningitis virus. Virology 1991, 163, 620-629.
73. Bruns, M.; Cihak, J.; Müller, G.; Lehmann-Grube, F. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 1983, 130, 247-251.
74. Parekh, B. S., Buchmeier, M. J. Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology 1986, 153, 168-178.
75. Borrow, P.; Oldstone, M. B. A. Characterization of lymphocytic choriomeningitis virus-binding protein (s): a candidate cellular receptor for the virus. J. Virol. 1992, 66, 7270-7281.
76. Scolaro, L. A.; Mersich, S. E.; Damonte, E. B. A mouse attenuated mutant of Junin virus with an altered envelope glycoprotein. Arch. Virol. 1990, 111, 257-262.
77. Cao, W.; Henry, M. D.; Borrow, P.; Yamada, H.; Elder, J. H.; Ravkov, E. V.; Nichol, S. T.; Compans, R. W.; Campbell, K. P.; Oldstone, M. B. A. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 1998, 282, 2079-2081.
78. Henry, M. D.; and Campbell, K. P. Dystroglycan inside and out. Curr. Opin. Cell Biol. 1999, 11, 602-607.
79. Spiropoulou, C. F.; Kunz, S.; Rollin, P. E.; Campbell, K. P.; Oldstone, M. B. A. New World arenaviruses clade C, but not clade A and B viruses, utilizes α-dystroglycan as its major receptor. J. Virol. 2002, 76, 5140-5146.
80. Raiger Iustman, L. J.; Candurra, N.; Mersich, S. E. Influencia del tratamiento enzimatico sobre la interaction virus Junín-celulas Vero. Rev. Arg. Microbiol. 1995, 27, 28-32.
81. Schneider-Schaulies, J. Cellular receptors for viruses: links to tropism and pathogenesis. J. Gen. Virol. 2000, 81, 1413-1429.
82. Smelt, S. C.; Borrow, P.; Kunz, S.; Cao, W.; Tishon, A.; Lewicki, H.; Campbell, K. P.; Oldstone, M. B. A. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor α-dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 2001, 75, 448-457.
83. Witvrouw, M.; Desmyter, J.; De Clercq, E. Antiviral portrait series: 4. Polysulfates as inhibitors of HIV and other enveloped viruses. Antiviral Chem. Chemother. 1994, 5, 345-359.
84. Glushakova, S. E.; Lukashevich, I. S. Early events in arenavirus replication are sensitive to lysosomotropic compounds. Arch. Virol. 1989, 194, 157-161.
85. Castilla, V.; Mersich, S. E.; Candurra, N. A.; Damonte, E. B. The entry of Junin virus into Vero cells. Arch. Virol. 1994, 36, 363-374.
86. Borrow, P.; Oldstone, M. B. A. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 1994, 198, 1-9.
87. Castilla, V.; Palermo, L. M.; Coto, C. E. Involvement of vacuolar proton ATPase in Junin virus multiplication. Arch. Virol. 2001, 146, 251-263.
88. Di Simone, C.; Buchmeier, M. J. Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex. Virology 1995, 209, 3-9.
89. Di Simone, C.; Zandonatti, M. A.; Buchmeier, M. J. Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology 1994, 198, 455-465.
90. Castilla, V.; Mersich, S. E. Low-pH-induced fusion of Vero cells infected with Junin virus. Arch. Virol. 1996, 141, 1307-1317.
91. Glushakova, S. E.; Omelyanenko V. G.; Lukashevich, I. S.; Bogdanov, A. A.; Moshnikova, A. B.; Kozytch, A. T.; Torchilin, V. P. The fusion of artificial lipid membranes induced by the synthetic arenavirus fusion peptide. Biochim. Biophys. Acta 1992, 1110, 202-208.
92. Coto, C. E.; Calello, M. A.; Parodi, A. S. Efecto de la amantadina-HCl sobre la infectividad del virus Junín (FHA) in vitro e in vivo. Rev. Argent. Microbiol. 1969, 1, 3-8.
93. Pfau, C. J.; Trowbridge, R. S.; Welsh, R. M.; Staneck, L. D.; O'Connell, C. M. Arenaviruses: inhibition by amantadine hydrochloride. J. Gen. Virol. 1972, 14, 209-211.
94. Pfau, C. J. Arenavirus chemotherapy-retrospect and prospect. Bull. WHO 1975, 52, 737-744.
95. Candurra, N. A.; Maskin, L.; Damonte, E. B. Inhibition of arenavirus multiplication in vitro by phenotiazines. Antiviral Res. 1996, 31, 149-158.
96. Candurra, N. A.; Damonte, E. B. Accion inhibitoria de la cafeína sobre la multiplicación del virus Junín. Rev. Argent. Microbiol. 1999, 31, 135-141.
97. Wang, L. H.; Rothberg, K. G.; Anderson, R. G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 1993, 123, 1107-1117.
98. Candurra, N. A.; Lago, M. J.; Maskin, L.; Damonte, E. B. Involvement of the cytoskeleton in Junin virus multiplication. J. Gen. Virol. 1999, 80, 147-156.
99. Andrei, G.; Couto, A. S.; de Lederkremer, R. M.; Coto, C. E. Purification and partial characterization of an antiviral active peptide from Melia azedarach L. Antiviral Chem. Chemother. 1994, 5, 105-110.
100. Castilla, V.; Barquero, A. A.; Mersich, S. E.; Coto, C. E. In vitro anti-Junin virus activity of a peptide isolated from Melia azedarach L. leaves. Int. J. Antimicrob. Agents 1998, 10, 67-75.
101. Andrei, G. M.; Lampuri, J. S.; Coto, C. E.; de Torres, R. A. An antiviral factor from Melia azedarach L. prevents Tacaribe virus encephalitis in mice. Experientia 1986, 42, 843-845.
102. Murphy, F. A.; Webb, P. A.; Johnson, K. M.; Whitfield, S. G.; Chappell, W. A. Arenaviruses in Vero cells: ultrastructural studies. J. Virol. 1970, 6, 507-518.
103. Lenz, O.; terMeulen, J.; Feldmann, H.; Klenk, H.-D.; Garten, W. Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J. Virol. 2000, 74, 11418-11421.
104. Lenz, O.; ter Meulen, J.; Klenk, H. D.; Seidah, N. G.; Garten, W. The Lassa virus glycoprotein precursor GPC is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 12701-12705.
105. Beyer, W. R.; Popplau, D.; Garten, W.; von Laer, D.; Lenz, O. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J. Virol. 2003, 77, 2866-2872.
106. Wright, K. E.; Spiro, R. C.; Burns, W.; Buchmeier, M. J. Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus. Virology 1990, 177, 175-183.
107. Candurra, N. A.; Damonte, E. B. Effect of inhibitors of the intracellular exocytic pathway on glycoprotein processing and maturation of Junin virus. Arch. Virol. 1997, 142, 2179-2193.
108. Damonte, E. B.; Mersich, S. E.; Candurra, N. A. Intracellular processing and transport of Junin virus glycoproteins influences virion infectivity. Virus Res. 1994, 34, 317-326.
109. Kunz, S.; Edelmann, K. H.; de la Torre, J. C.; Gorney, R.; Oldstone, M. B. A. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology 2003, 314, 168-178.
110. Silber, A. M.; Candurra, N. A.; Damonte, E. B. The effects of oligosaccharide trimming inhibitors on glycoprotein expression and infectivity of Junin virus. FEMS Microbiol. Lett. 1993, 109, 39-44.
111. Romanowski, V. Genetic organization of Junin virus, the etiological agent of Argentine hemorrhagic fever. In The Arenaviridae, Salvato, M. S. (ed.). Plenum Press, New York, 1993, pp. 51-84.
112. Cordo, S. M.; Candurra, N. A.; Damonte, E. B. Myristic acid analogs are inhibitors of Junin virus replication. Microbes Infect. 1999, 1, 609-614.
113. Bartolotta, S.; García, C. C.; Candurra, N. A.; Damonte, E. B. Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch. Virol. 2001, 146, 777-790.
114. Salvato, M. S.; Shimomaye, E. M. The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology 1989, 173, 1-10.
115. Iapalucci, S.; Lopez, N.; Rey, O.; Zakin, M. M.; Cohen, G. N.; Franze-Fernandez, M. T. The 5' region of Tacaribe virus L RNA encodes a protein with a potential metal binding domain. Virology 1989, 173, 357-361.
116. Djavani, M.; Lukashevich, I. S.; Sanchez, A.; Nichol, S. T.; Salvato, M. S. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' end. Virology 1997, 235, 414-418.
117. Gibadulinova, A.; Zelnik, V.; Reiserova, L.; Zavodska, E.; Zatovicova, M.; Ciampor, F.; Pastorekova, S.; Pastorek, J. Sequence and characterisation of the Z gene encoding ring finger protein of the lymphocytic choriomeningitis virus MX strain. Acta Virol. 1998, 42, 369-374.
118. Salvato, M. S.; Schweighofer, K. J.; Burns, J.; Shimomaye, E. M. Biochemical and immunological evidence that the 11-kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res. 1992, 22, 185-198.
119. Garcin, D.; Rochat, S.; Kolakofsky, D. The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication. J. Virol. 1993, 67, 807-812.
120. Lee, K. J.; Novella, I. S.; Teng, M. N.; Oldstone, M. B. A.; de la Torre, J. C. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 2000, 74, 3470-3477.
121. Cornu, T. I.; de la Torre, J. C. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 2001, 75, 9415-9426.
122. Lopez, N.; Jacamo, R.; Franze-Fernandez, M. T. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J. Virol. 2001, 75, 12241-12251.
123. Borden, K. L.; Campbell-Dwyer, E. J.; Salvato, M. S. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett. 1997, 418, 30-34.
124. Borden, K. L.; Campbell-Dwyer, E. J.; Salvato, M. S. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 1998, 72, 758-766.
125. Borden, K. L. B.; Campbell-Dwyer, E. J.; Carlile, G. W.; Djavani, M.; Salvato, M. S. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J. Virol. 1998, 72, 3819-3826.
126. Campbell-Dwyer, E. J.; Lai, H.; MacDonald, R. C.; Salvato, M. S.; Borden, K. L. B. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J. Virol. 2000, 74, 3293-3300.
127. Salvato, M. S. Molecular biology of the prototype arenavirus, lymphocytic choriomeningitis virus. In The Arenaviridae, Salvato, M. S. (ed.). Plenum Press, New York, 1993, pp. 133-156.
128. Garoff, H.; Hewson, R.; Opstelten, D. J. Virus maturation by budding. Microbiol. Mol. Biol. Rev. 1998, 62, 1171-1190.
129. Strecker, T.; Eichler, R.; ter Meulen, J.; Weissenhorn, W.; Klenk, H. D.; Garten, W.; Lenz, O. Lassa virus Z protein is a matrix protein and sufficient for the release of viruslike particles. J. Virol. 2003, 77, 10700-10705.
130. Perez, M; Craven, R. C.; de la Torre, J. C. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 12978-12983.
131. Eichler, R.; Strecker, T.; Kolesnikova, L.; ter Meulen, J.; Weissenhorn, W.; Becker, S.; Klenk, H. D.; Garten, W.; Lenz, O. Characterization of the Lassa virus matrix protein: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res. 2004, 100, 249-255.
132. Freed, E. O. Viral late domains. J. Virol. 2002, 76, 4679-4687.
133. Cornu, T. I.; de la Torre, J. C. Characterization of the arenavirus RING finger protein regions required for Z-mediated inhibition of viral RNA synthesis. J. Virol. 2002, 76, 6678-6688.
134. García, C. C.; Candurra, N. A.; Damonte, E. B. Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds. Antiviral Chem. Chemother. 2000, 11, 231-238.
135. Rice, W. G.; Turpin, J. A.; Schaeffer, C. A.; Graham, L.; Clanton, D.; Buckheit, R. W. Jr.; Zaharevitz, D.; Summers, M. F.; Wallquist, A.; Covell, D. G. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. 1996, 39, 3603-3616.
136. Rice, W. G.; Turpin, J. A.; Huang, M.; Clanton, D.; Buckheit, R. W. Jr.; Covell, D. G.; Wallquist, A.; McDonnell, N. B.; de Guzman, R. N.; Summers, M. F.; Zalkow, L.; Bader, J. P.; Haugwitz, R.; Sausville, E. A. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nat. Med. 1997, 3, 341-345.
137. Tummino, P. J.; Harvey, P. J.; McQuade, T.; Domagala, J.; Gogliotti, R.; Sanchez, J.; Song, Y.; Hupe, D. The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. Antimicrob. Agents Chemother. 1997, 41, 394-400.
138. García, C. C.; Candurra, N. A.; Damonte, E. B. Mode of inactivation of arenaviruses by disulfide-based compounds. Antiviral Res. 2002, 55, 437-446.
139. García, C. C.; Candurra, N. A.; Damonte, E. B. Differential inhibitory action of two azoic compounds against arenaviruses. Int. J. Antimicrob. Agents 2003, 21, 319-324.
140. García, C. C.; Candurra, N. A.; Damonte, E. B. Arenavirus inactivation with conservation of virus surface glycoprotein and blockade in viral transcription. Antiviral Res. 2003, 57, A91.
141. Garcíía, C. C. Unpublished results, 2004.
142. Wachsman, M. B.; Lopez, E. M. F.; Ramírez, J. A.; Galagovsky, L. R.; Coto, C. E. Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antiviral Chem. Chemother. 2000, 11, 71-77.
143. Comin, M. J.; Maier, M. S.; Roccatagliata, A. J.; Pujol, C. A.; Damonte, E. B. Evaluation of the antiviral activity of natural sulfated polyhydroxysteroids and their synthetic derivatives and analogs. Steroids 1999, 64, 335-340.
144. García, C. C.; Rosso, M. L.; Bertoni, M. D.; Maier, M. S.; Damonte, E. B. Evaluation of the antiviral activity against Junin virus of macrocyclic trichothecenes produced by the hypocrealean epibiont of Baccharis coridifolia. Planta Med. 2002, 68, 209-212.
145. García, C. C.; Brousse, B. N.; Carlucci, M. J.; Moglioni, A. G.; Martins Alho, M.; Moltrassio, G. Y.; D'Accorso, N. B.; Damonte, E. B. Inhibitory effect of thiosemicar-bazone derivatives on Junin virus replication in vitro. Antiviral Chem. Chemother. 2003, 14, 99-105.
146. Albiol Matanic, V.; Castilla, V. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int. J. Antimicrob. Agents 2004, 23, 382-389.
147. Maiztegui, J. I.; McKee, K. T.; BarreraOro, J. G.; Harrison, L. H.; Gibbs, P. H.; Feuillade, M. R.; Enria, D. A.; Briggiler, A. M.; Levis, S. C.; Ambrosio, A. M.; Halsey, N. A.; Peters, C. J.; AHF Study Group. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J. Infect. Dis. 1998, 177, 277-283.